AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2021
May 20, 2021
35124_dirs_2021-05-20_67e9fbd5-58c8-4ab8-8135-e690d3a47604.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-05-17
Reporting Person: Braun Donald P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-17 | Celsion Corporation Common Stock | P | 5000 | $1.07 | Acquired | 5357 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23